Apheresis Medical Director
Grace Fortes Monis is not currently accepting new patients. For assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Blood Banking/Transfusion Medicine
Apheresis and Special Coagulation
I consider the patient to be a crucial part of the health care team. A patient's participation, opinion, and choices matter in reaching their health care goals. Is is an honor to serve as a health care provider at UC Davis Medical Center.
Dr. Monis is a transfusion medicine physician for the Apheresis, Blood Bank, and Special Coagulation service. She provides care to many patient populations including those needing Hematopoietic Stem Cell Collection, automated Red Cell Exchange, Plasma Exchange and Extracorporeal Photopheresis.
Dr. Monis is encourages patient oriented and appropriate use of blood products. She promotes patient and children education, waste reduction, use of databases/informatics and efficient process management.
Dr. Monis has research interests in the improvement of blood product quality and administration. Some of her previous studies investigate hematologic pathology (including disseminated intravascular coagulopathy (DIC); microparticle formation; lupus inhibitors; hemophilia). She has also worked with new assay development and/or application (ex. for blood component quality monitoring or lupus inhibitors). Dr. Monis is active on National (ASFA) Apheresis Research committees to collecting data on best treatment practices.
B.S., San Jose State University, San Jose CA 1998
M.D., Boston University School of Medicine, Boston MA 2008
Ph.D., Pathology, Boston University School of Medicine, Boston MA 2008
Pathology, University of Washington, Seattle WA 2008-2009
Pathology, University of Washington, Seattle WA 2008-2012
Transfusion Medicine, UC Davis Medical Center, Sacramento CA 2015-2016
Lab Medicine / Hemophilia, University of Washington, Seattle WA 2012-2015
UC Davis Clinical Pathology Faculty Teaching Award, 2020
California Blood Bank Society (CBBS) Educational Scholarship, 2016
University of Washington Medical Center Teacher Recognition, 2015
Bayer Hemophilia Fellowship Award 2013, 2014, 2015
The Leonard and Julius Gottlieb Prize Fund in Pathology Education, 2008
Ipe TS, Raval JS, Fernando LP, Gokhale A, Jacquot C, Johnson AD, Kim HC, Monis GF, Mo YD, Morgan SM, Pagano MB, Pham HP, Sanford K, Schmidt AE, Schwartz J, Waldman A, Webb J, Winters JL, Wu Y, Yamada C, Wong ECC. Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee. J Clin Apher. 2020 Jan;35(1):25-32. doi:10.1002/jca.21754. Epub 2019 Nov 9. PMID:31705563.
Harm SK, Yazer MH, Monis GF, Triulzi DJ, Aubuchon JP, Delaney M. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Am J Clin Pathol. 2014 Feb;141(2):256-61. doi:10.1309/AJCP47QAAXTOZEKJ. PMID:24436274.
Laboratory Management of Disseminated Intravascular Coagulation (DIC). BH Shaz BH, et al (eds). Transfusion Medicine and Hemostasis Clinical and Laboratory Aspects, 2nd Edition. 2013;140:937-40.
Monis G, Ferrell C, Reyes M. Lupus anticoagulant increases activated partial thromboplastin time (PTT) prolongation in incubated 1:1 mix. Clin Lab Sci. 2012 Summer;25(3):165-9. PMID:22953516.
Amyloid Light Chains Localize to Lysosomes and Cardiac Fibroblasts Show Reduced Mitochondrial Function. M Skinner M (eds). XIth International Symposium on Amyloidosis, CRC Press. 2008:22-24.
Monis GF, Schultz C, Ren R, Eberhard J, Costello C, Connors L, Skinner M, Trinkaus-Randall V. Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts. Am J Pathol. 2006 Dec;169(6):1939-52. doi:10.2353/ajpath.2006.060183. PMID:17148659.
Trinkaus-Randall V, Walsh MT, Steeves S, Monis G, Connors LH, Skinner M. Cellular response of cardiac fibroblasts to amyloidogenic light chains. Am J Pathol. 2005 Jan;166(1):197-208. doi:10.1016/S0002-9440(10)62244-4. PMID:15632012.
Internalization of Systemic Amyloid Light Chains and Heparan Sulfate Proteoglycan Deposition. Grateau G, Kyle RA, Skinner M (eds.) Amyloid and Amyloidosis, CRC Press. 2005:142–144.